A clinical comparison of rapamycin (sirolimus) and low-dose naltrexone (LDN) side-effect profiles for longevity and immune-modulation use, with trial data, dosing context, and prescriber guidance.
A comparison of tadalafil (Cialis) vs generic sildenafil across dose ranges, onset, duration, side effects, and real-world trial data to help you choose the right PDE5 inhibitor.
Cialis (brand tadalafil) and generic tadalafil contain the same molecule at identical doses. This HealthRX.com clinical review compares efficacy, onset, duration, dosing, cost, and safety across every approved indication so you can make an informed choice with your prescriber.
A detailed head-to-head comparison of testosterone cypionate and testosterone enanthate side-effect profiles, dosing schedules, injection site reactions, and clinical outcomes for men on TRT.
A clinical comparison of testosterone cypionate and testosterone enanthate for TRT, including pharmacokinetics, dosing, injection schedules, and a step-by-step protocol for switching between them safely.
A clinical comparison of testosterone enanthate injections and Jatenzo oral testosterone undecanoate covering side-effect profiles, cardiovascular risk, hematocrit, blood pressure, and how to choose between them.
A comparison of ipamorelin acetate vs CJC-1295 (modified GRF 1-29): mechanisms, GH pulse data, IGF-1 outcomes, dosing, side effects, and when to use each peptide or combine them.
A clinical head-to-head comparison of ipamorelin acetate and tesamorelin (Egrifta) side-effect profiles, mechanism differences, dosing, and which peptide may suit your goals, prepared by the HealthRX.com Editorial Team.
A clinical comparison of sermorelin acetate and ipamorelin acetate, covering mechanism, dosing, side effects, and how to switch between them safely.
A direct comparison of BPC-157 pentadecapeptide and copper tripeptide GHK-Cu across wound healing, tendon repair, anti-inflammatory action, and collagen synthesis, with every claim tied to primary sources.
A direct comparison of the side-effect profiles of PT-141 (bremelanotide) and epitalon tetrapeptide, covering nausea rates, cardiovascular signals, injection-site reactions, and long-term safety data from clinical trials and published research.
A detailed clinical comparison of thymosin alpha-1 (thymalfasin) and AOD-9604 (HGH fragment 176-191) side-effect profiles, mechanisms, dosing, and use cases, prepared by the HealthRX.com Editorial Team.
A clinical comparison of thymosin alpha-1 (thymalfasin) and AOD-9604 (HGH fragment 176-191), covering mechanisms, evidence, and how to switch between them safely.
A direct clinical comparison of thymosin alpha-1 (thymalfasin) and MOTS-c mitochondrial peptide covering mechanisms, evidence quality, compounding access, pricing, and how to choose between them.
A clinical comparison of dutasteride (Avodart) and isotretinoin (Accutane) covering mechanisms, indications, safety profiles, and how to switch between them safely.
A detailed comparison of dutasteride (Avodart) and spironolactone covering efficacy for hair loss and hormonal acne, cost, insurance coverage, off-label use, and how to choose between them.
A clinical comparison of finasteride and spironolactone covering mechanism, efficacy evidence, monthly cost, insurance coverage, and who qualifies for each drug.
A detailed clinical comparison of finasteride and spironolactone side-effect profiles, covering sexual dysfunction, electrolyte risks, hormonal effects, and which drug suits which patient.
A direct clinical and cost comparison of low-dose oral minoxidil for hair loss versus isotretinoin (Accutane) for acne. Learn which drug fits your condition, budget, and access pathway.
A clinical comparison of low-dose oral minoxidil and isotretinoin (Accutane), including when to switch, how to switch safely, and what the evidence says about each drug's efficacy, dosing, and side-effect profile.
A direct clinical comparison of oral low-dose minoxidil versus topical 5% minoxidil for hair loss, covering efficacy data, side-effect profiles, real costs, and how to access each form through a telehealth provider.
A comparison of low-dose oral minoxidil and topical tretinoin covering indications, side-effect profiles, and a step-by-step protocol for switching between the two.
A direct comparison of topical minoxidil 5% and oral spironolactone side effects, efficacy data, and clinical use cases for hair loss and hormonal acne in women.
A detailed clinical comparison of tretinoin (topical retinoid) and Avodart (dutasteride) covering indications, efficacy data, cost, insurance coverage, and telehealth access for patients and clinicians.
A clinical comparison of tretinoin (topical retinoid) and Avodart (dutasteride) covering mechanisms, evidence, and the decision framework for switching between them.
A detailed clinical comparison of tretinoin topical and oral isotretinoin covering efficacy, cost, access requirements, side-effect profiles, and how to choose between them for acne and skin concerns.
A comparison of tretinoin and topical minoxidil, covering mechanisms, clinical evidence, and how to switch safely between them for skin and hair goals.
A clinical comparison of eszopiclone (Lunesta) and trazodone for insomnia, including the evidence base for combining them, pharmacology, switching protocols, and safety data prepared by the HealthRX.com Editorial Team.
A comparison of eszopiclone (Lunesta) and trazodone for insomnia, including how to switch between them, dosing, safety data, and which patients do better on each drug.
A clinical comparison of suvorexant (Belsomra) and lemborexant (Dayvigo) covering efficacy, safety, next-morning alertness, and a step-by-step protocol for switching between them.
Liraglutide and retatrutide: what studies show, whether switching or combining is established, and how product, access and population differences matter.
A clinical deep-dive into tirzepatide (Mounjaro) vs dulaglutide (Trulicity), why combining them is contraindicated, when switching makes sense, and what head-to-head trial data actually show.
A clinical comparison of tirzepatide (Mounjaro) and dulaglutide (Trulicity) covering titration schedules, GI tolerability, weight loss, and HbA1c outcomes to help patients and clinicians choose the right GLP-1 therapy.
A clinical deep-dive comparing tirzepatide (Mounjaro) and liraglutide (Saxenda) for weight loss, examining whether combining or sequencing them makes sense, what the evidence shows, and how to switch safely.
A clinical comparison of semaglutide (Ozempic) and dulaglutide (Trulicity) covering efficacy, tolerability, and a step-by-step protocol for switching when one GLP-1 stops working.
A comparison of Wegovy (semaglutide 2.4 mg) and Saxenda (liraglutide 3 mg), covering efficacy data, the rationale people cite for combining them, and why co-administration is not supported or approved.
A head-to-head comparison of Zepbound (tirzepatide) and Ozempic (semaglutide) using clinical trial data, real-world evidence, and physician guidance on switching. prepared by the HealthRX.com Editorial Team.
A head-to-head clinical comparison of NMN/NR (nicotinamide mononucleotide/riboside) versus compounded low-dose naltrexone for long-term durability, covering trial data, mechanism, dose, and which patients are likely to respond best over time.
A clinical comparison of NMN/NR (nicotinamide mononucleotide/riboside) and low-dose naltrexone across special populations including older adults, autoimmune patients, cancer survivors, and metabolic disease, with dosing, evidence grades, and switching criteria.
A clinical comparison of rapamycin (sirolimus) and NMN/NR (nicotinamide mononucleotide/riboside) for longevity, including mechanism differences, trial data, combination rationale, and real risks.
A detailed clinical comparison of oral estradiol and vaginal estradiol side-effect profiles, covering systemic absorption, VTE risk, breast tissue exposure, and when each route is the right choice for menopausal women.
A clinical comparison of estradiol patch versus oral estradiol covering pharmacokinetics, safety, cost, insurance coverage, and access, with primary-source citations throughout.
A clinical comparison of transdermal estradiol patch vs oral estradiol for menopausal HRT. Covers efficacy, VMS relief, cardiovascular risk, clot risk, bone protection, and how to choose.
A clinical comparison of oral micronized progesterone (Prometrium) and oral estradiol for menopausal HRT, covering endometrial protection, vasomotor symptom relief, cardiovascular effects, bone density, and safety profiles with trial data.
A detailed clinical comparison of oral micronized progesterone and Prometrium for women's HRT, including trial data, dosing, safety profiles, and when each is preferred.
Perimenopause and menopause drive real psychiatric symptoms including depression, anxiety, and cognitive changes. Learn how to diagnose the overlap, which treatments work, and what major society guidelines recommend.
Evidence-based strategies to prevent the return of menopause symptoms, protect bone density, support cardiovascular health, and sustain quality of life. prepared by the HealthRX.com Editorial Team.
A clinician-grade, step-by-step guide to diagnosing metabolic syndrome using ATP III, IDF, and harmonized AHA/NHLBI criteria, plus evidence-based treatment pathways for all five components.
How partners and family members can support obesity treatment. Evidence-based strategies covering shared lifestyle change, emotional support, medication adherence, and what the guidelines say.
A complete walkthrough of the OSA diagnostic algorithm: screening tools, home vs. Lab sleep testing, AHI thresholds, severity classification, and first-line treatment options including CPAP, weight loss, and tirzepatide (Zepbound).
A guide for caregivers and family members supporting someone with PCOS. Covers diagnosis, treatment options, emotional support strategies, and when to seek specialist care.
PCOS is a hormonal and metabolic condition that affects an estimated 6-12% of reproductive-age women and is associated with a meaningfully higher rate of depression, anxiety, and disordered eating. This article explains the plausible mechanisms, how clinicians screen, what treatments have evidence behind them, and where the research is still incomplete.
An evidence-based PCOS treatment algorithm organized by line of therapy, covering lifestyle, metformin, combined oral contraceptives, letrozole, GLP-1 agonists, and surgical options with full citations.
A clinical guide to the conditions that commonly co-occur with perimenopause, including thyroid disease, metabolic syndrome, mood disorders, sleep disturbance, and cardiovascular risk, with guidance on what to screen for and when to escalate care.
Learn how genetics and family history shape perimenopause timing, symptom severity, and treatment options. Evidence-based guidance from the HealthRX.com medical team, with citations to primary research.
How partners and family members can support someone through perimenopause, including symptom education, communication strategies, and when to encourage professional care.
A guideline-based treatment algorithm for perimenopause: first-line, second-line, and third-line options for vasomotor symptoms, cycle irregularity, mood disturbance, and bone protection, with dosing, evidence grades, and society recommendations.
Prediabetes and mental health disorders share overlapping biology, risk factors, and treatment gaps. Learn how depression, anxiety, and chronic stress drive glucose dysregulation, and what clinical guidelines say about screening and treating both.
A guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
A guide to exercise protocols for secondary hypogonadism, covering resistance training, HIIT, aerobic work, and how structured movement affects LH, FSH, and testosterone recovery.